검색어: ankilozirajočem (슬로베니아어 - 영어)

neželeni učinki pri ankilozirajočem spondilitisu
adverse reactions in ankylosing spondylitis

ponovna uporaba zdravila pri ankilozirajočem spondilitisu
re-administration for ankylosing spondylitis

pogostnost nevtropenije je pri psoriatičnem artritisu in ankilozirajočem spondilitisu podobna kot pri psoriazi.
the frequency of neutropenia in psoriatic arthritis and ankylosing spondylitis is similar to psoriasis.

pri ankilozirajočem spondilitisu vam bo uporaba zdravila cosentyx koristila, saj bo zmanjševala znake in simptome bolezni ter izboljševala vašo telesno zmogljivost.
using cosentyx in ankylosing spondylitis will benefit you by reducing the signs and symptoms of your disease and improving your physical function.

tabela 10 - odzivi učinkovitosti v študiji pri ankilozirajočem spondilitisu, kontrolirani s placebom - študija i zmanjšanje znakov in simptomov
21 table 10– efficacy responses in placebo-controlled as study – study i reduction of signs and symptoms

mnogo sprememb sklepov pri revmatoidnem artritisu in ankilozirajočem spondilitisu ter sprememb na koži pri psoriazi v plakih posredujejo vnetne molekule, povezane v mrežo, ki jo nadzira tnf.
much of the joint pathology in rheumatoid arthritis and ankylosing spondylitis and skin pathology in plaque psoriasis is mediated by pro-inflammatory molecules that are linked in a network controlled by tnf.

21 rezultati obsežnejše študije pri ankilozirajočem spondilitisu i pri 315 bolnikih so pri bolnikih, ki so dobivali humiro, pokazali statistično značilno izboljšanje znakov in simptomov ankilozirajočega spondilitisa v primerjavi s placebom.
in the larger as study i with 315 patients, results showed statistically significant improvement of the signs and symptoms of ankylosing spondylitis in patients treated with humira compared to placebo.

38 a ocene pri ankilozirajočem spondilitisu (assessments in ankylosing spondylitis) b bathov indeks bolezenske aktivnosti ankilozirajočega spondilitisa (bath ankylosing spondylitis disease activity index)
ed b bath ankylosing spondylitis disease activity index

t me a ocene pri ankilozirajočem spondilitisu (assessments in ankylosing spondylitis) b bathov indeks bolezenske aktivnosti ankilozirajočega spondilitisa (bath ankylosing spondylitis disease activity index)
tho a assessments in ankylosing spondylitis b bath ankylosing spondylitis disease activity index

podobni trendi (ki pa niso bili vsi statistično značilni) so bili opazni v manjši, randomizirani, dvojno slepi, s placebom kontrolirani študiji pri ankilozirajočem spondilitisu ii pri 82 odraslih bolnikih z aktivnim ankilozirajočim spondilitisom.
similar trends (not all statistically significant) were seen in the smaller randomised, double − blind, placebo controlled as study ii of 82 adult patients with active ankylosing spondylitis.